[Inhibition of antibody production of sensitized animals. 1. Comparison of cyclophosphamide and combined cyclophosphamide antigen-treatment (author's transl)].
D000477:Alkylating Agents; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D000941:Antigens; D003429:Cross Reactions; D003520:Cyclophosphamide / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D006388:Hemagglutinins / Q000032:analysis; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary; D007165:Immunosuppression Therapy; D008623:Mercaptoethanol; D051379:Mice / Q000276:immunology; D051381:Rats; D011919:Rats, Inbred Strains
D000477:Alkylating Agents; D000941:Antigens; D006388:Hemagglutinins; D008623:Mercaptoethanol; D003520:Cyclophosphamide
Hemmung der Antik-5aorperbildung sensibilisierter Tiere I. Vergleich von Cyclophosphamid Antigen-Behandlung Antigen-Behandlung- und Cyclophosphamid